Related Experiment Video

Updated: Jan 21, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.1K

New and Emerging Therapies for Pediatric Atopic Dermatitis

Henry L Nguyen1, Katelyn R Anderson1, Megha M Tollefson2

  • 1Department of Dermatology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55902, USA.

Paediatric Drugs
|August 1, 2019
PubMed

Insights

New therapies offer improved efficacy and safety for atopic dermatitis (AD). Emerging treatments like JAK-STAT inhibitors and biologics show promise for managing this chronic inflammatory skin condition.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Atopic dermatitis (AD) is a chronic inflammatory skin disease with limited treatment options.
  • Current therapies have potential side effects and variable efficacy.
  • Understanding AD pathogenesis has led to targeted therapeutic approaches.

Purpose of the Study:

  • To review novel and emerging therapies for atopic dermatitis.
  • To discuss the mechanisms of action for these new treatments.
  • To evaluate the potential of these therapies based on clinical data.

Main Methods:

  • Review of recent clinical studies on new atopic dermatitis treatments.
  • Analysis of mechanisms of action for emerging drugs.
  • Synthesis of data on efficacy and safety profiles.

Main Results:

  • FDA-approved crisaborole and dupilumab offer new treatment avenues.
  • JAK-STAT inhibitors demonstrate promising results in clinical trials.
  • Other emerging therapies include IL-4/IL-13 antagonists and IL-31Rα antagonists.

Conclusions:

  • Novel therapies targeting specific pathways show increased efficacy for AD.
  • Emerging treatments have the potential for fewer systemic side effects compared to traditional options.
  • Further research and clinical data will define the role of these new agents in AD management.

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.1K
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

3.5K

Related Concept Videos

Emerging Adulthood01:27

Emerging Adulthood

Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
640
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
300
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Applications of GIS: Disaster Management and Emergency Response01:29

Applications of GIS: Disaster Management and Emergency Response

Geographic Information System (GIS) technology is essential for risk identification, action prioritization, and resource optimization in critical situations like flooding and earthquakes. By integrating spatial and demographic data, GIS provides a comprehensive framework for emergency response.GIS integrates data layers, like rainfall intensity, topography, elevation profiles, and river levels, to model high-risk flood zones. These layers assess areas susceptible to flooding based on their...
482
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
263